XML 169 R100.htm IDEA: XBRL DOCUMENT
v3.23.1

Goodwill and intangible assets (Details 1) - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
--- | --- | --- | ---
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | $ 60,945 | $ 63,777 |
Operating segments [member] | Innovative Medicines |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 51,357 | 53,919 |
Operating segments [member] | Sandoz |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 9,230 | 9,603 |
Operating segments [member] | Corporate |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 358 | 255 |
Goodwill |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 29,301 | 29,595 | $ 29,999
Goodwill | Operating segments [member] | Innovative Medicines |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 21,531 | 21,562 |
Goodwill | Operating segments [member] | Sandoz |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 7,770 | 8,026 |
Goodwill | Operating segments [member] | Corporate |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value |  | 7 |
Intangible Assets other than Goodwill |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 31,644 | 34,182 | 36,809
Intangible Assets other than Goodwill | Operating segments [member] | Innovative Medicines |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 29,826 | 32,357 |
Intangible Assets other than Goodwill | Operating segments [member] | Sandoz |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 1,460 | 1,577 |
Intangible Assets other than Goodwill | Operating segments [member] | Corporate |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 358 | 248 |
Acquired research and development [member] |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 4,421 | 5,499 | 4,700
Acquired research and development [member] | Operating segments [member] | Innovative Medicines |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 4,186 | 5,313 |
Acquired research and development [member] | Operating segments [member] | Sandoz |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 235 | 186 |
Technologies |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 121 | 177 | 230
Technologies | Operating segments [member] | Innovative Medicines |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 14 | 15 |
Technologies | Operating segments [member] | Sandoz |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 107 | 162 |
Currently marketed products |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 25,513 | 27,106 | 30,767
Currently marketed products | Operating segments [member] | Innovative Medicines |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 24,487 | 25,938 |
Currently marketed products | Operating segments [member] | Sandoz |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 1,026 | 1,168 |
Other intangible assets |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 1,589 | 1,400 | $ 1,112
Other intangible assets | Operating segments [member] | Innovative Medicines |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 1,139 | 1,091 |
Other intangible assets | Operating segments [member] | Sandoz |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | 92 | 61 |
Other intangible assets | Operating segments [member] | Corporate |  |  |
Disclosure of detailed information about intangible assets [line items] |  |  |
Net book value | $ 358 | $ 248 |

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfIntangibleAssetsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_IntangibleAssetsAndGoodwill
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=nvs_SandozMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=nvs_CorporateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |